SCHEMBL8939745

SCHEMBL8939745

[c]1ccc(Cc2ccccc2)c(OCc2ccccc2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.45
HTR1A P08908 1/20 0.45
L3MBTL1 Q9Y468 2/20 0.43
MAPT P10636 1/20 0.43
MAPK1 P28482 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
NISCH Q9Y2I1 1/20 0.40
LIPE Q05469 1/20 0.40
HRH1 P35367 2/20 0.40
DRD1 P21728 1/20 0.40
DRD4 P21917 1/20 0.40
DRD5 P21918 1/20 0.40
LTA4H P09960 1/20 0.39
MAPK14 Q16539 1/20 0.39
RXRA P19793 1/20 0.39
RXRB P28702 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27492385 0.85 MAOB (0.44) DRD2HTR1AL3MBTL1MAPTMAPK1
SCHEMBL8939788 0.85 DRD1 (0.43) DRD2HTR1AL3MBTL1MAPTHPGD
SCHEMBL27698309 0.83 DRD2 (0.57) DRD2HTR1AL3MBTL1MAPTMAPK1
SCHEMBL183414 0.82 MAPT (0.48) DRD2HTR1AL3MBTL1MAPTMAPK1
SCHEMBL8859966 0.81 HTR1A (0.43) DRD2HTR1AL3MBTL1HPGDSMN1; SMN2
SCHEMBL1616139 0.79 MAPT (0.55) DRD2HTR1AL3MBTL1MAPTMAPK1
SCHEMBL10601013 0.78 DRD2 (0.69) DRD2HTR1AL3MBTL1MAPTMAPK1
SCHEMBL1691977 0.78 HPGD (0.46) DRD2HTR1AL3MBTL1MAPTMAPK1
SCHEMBL7003209 0.78 APP (0.47) DRD2HTR1AL3MBTL1MAPTMAPK1
SCHEMBL22325285 0.78 MAPT (0.44) DRD2HTR1AL3MBTL1MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5516797-A SUPPRESSING GRAFT REJECTION VERTEX PHARMACEUTICALS, INCORPORATED (US) 1996-05-14 US disclosed
US-5330993-A Immunosuppressive compounds VERTEX PHARMACEUTICALS, INC. (US) 1994-07-19 US disclosed